You are here:
NIAMS Social Media
Updated November 2, 2012
NIAMS maintains the following Twitter accounts: The NIH Rheumatology Fellowship Program See the Twitter Moderation Policy. If you are using Internet Explorer to view Twitter pages, you may have trouble with any version older than IE8. Please try another browser.
|
NIAMS maintains the following Facebook pages: National Institute of Arthrits and Musculoskeletal and Skin Diseases (NIAMS) NIH Rheumatology Fellowship Training Program See the Facebook Comments Moderation Policy. |
Twitter Moderation Policy
The NIAMS reserves the right to monitor all replies to its tweets. Individuals commenting in their official capacity on any platform must identify their Agency relationship. The NIAMS reserves the right to block individuals from following the NIAMS if they reply to the NIAMS tweets with tweets that contain the following:
- Political endorsements of parties, candidates, or groups
- Commercial endorsements of products, services, organizations, or other entities
- Content that infringes on copyrights
- Comments on any ongoing investigation of any sort
- Discriminatory, racist, abusive, obscene, inflammatory, unlawful, or otherwise objectionable statements, language, or content
- Solicitations of funds
- Procurement-sensitive information related to any current/future NIAMS acquisitions
Facebook Comments Moderation Policy
The NIAMS reserves the right to monitor all postings to its Facebook page(s). Individuals commenting in their official capacity on any platform must identify their Agency relationship. Comments that contain the following will be deleted:
- Political endorsements of parties, candidates, or groups
- Commercial endorsements of products, services, organizations, or other entities
- Content that infringes on copyrights
- Comments on any ongoing investigation of any sort
- Discriminatory, racist, abusive, obscene, inflammatory, unlawful, or otherwise objectionable statements, language, or content
- Solicitations of funds
- Procurement-sensitive information related to any current/future NIAMS acquisitions